Trinsect Solutions OÜ

Active Registry code 14559188 OÜ Aasuvälja küla Registered 5 Sep 2018
Compare

Trinsect Solutions OÜ is a OÜ based in Aasuvälja küla, registry code 14559188, status: active. Main activity: Research and experimental development on biotechnology. According to EMTA, turnover for Q3 2026 was €0 with employees.

Turnover
0 €
State taxes
74 €
↓ 97.2% vs Q2 2026
Labour taxes
0 €
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
05 00010 00015 00020 000Q4 2023 Company: 0 € Industry median: 15 375 €Q4·23Q1 2024 Company: 0 € Industry median: 14 938 €Q2 2024 Company: 0 € Industry median: 14 999 €Q2·24Q3 2024 Company: 0 € Industry median: 11 985 €Q4 2024 Company: 0 € Industry median: 16 752 €Q4·24Q1 2025 Company: 0 € Industry median: 15 203 €Q2 2025 Company: 0 € Industry median: 14 420 €Q2·25Q3 2025 Company: 0 € Industry median: 13 763 €Q4 2025 Company: 0 € Industry median: 13 976 €Q4·25Q1 2026 Company: 0 € Industry median: 14 268 €Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26Q3 2026 Company: 0 € Industry median: 14 442 €Q3·2605 00010 00015 00020 000Q4 2024 Company: 0 € Industry median: 16 752 €Q1 2025 Company: 0 € Industry median: 15 203 €Q1·25Q2 2025 Company: 0 € Industry median: 14 420 €Q3 2025 Company: 0 € Industry median: 13 763 €Q3·25Q4 2025 Company: 0 € Industry median: 13 976 €Q1 2026 Company: 0 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q3 2026 Company: 0 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q4 2024: 2 944 € · +22.1% vs Q3 2024 · industry median 1 673 € · above 64% of the industry
01 0002 0003 000Q4 2023 Company: 2 436 € Industry median: 1 866 €Q4·23Q1 2024 Company: 2 422 € Industry median: 2 040 €Q2 2024 Company: 2 461 € Industry median: 2 008 €Q2·24Q3 2024 Company: 2 411 € Industry median: 1 961 €Q4 2024 Company: 2 944 € Industry median: 1 673 €Q4·24Q1 2025 Company: — Industry median: 1 781 €Q2 2025 Company: — Industry median: 1 781 €Q2·25Q3 2025 Company: — Industry median: 2 044 €Q4 2025 Company: — Industry median: 2 069 €Q4·25Q1 2026 Company: — Industry median: 2 039 €Q2 2026 Company: — Industry median: 1 893 €Q2·26Q3 2026 Company: — Industry median: 2 218 €Q3·2601 0002 0003 000Q4 2024 Company: 2 944 € Industry median: 1 673 €Q1 2025 Company: — Industry median: 1 781 €Q1·25Q2 2025 Company: — Industry median: 1 781 €Q3 2025 Company: — Industry median: 2 044 €Q3·25Q4 2025 Company: — Industry median: 2 069 €Q1 2026 Company: — Industry median: 2 039 €Q1·26Q2 2026 Company: — Industry median: 1 893 €Q3 2026 Company: — Industry median: 2 218 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q4 2024: 3 · +0.0% vs Q3 2024
0123Q4 2023 Company: 3Q4·23Q1 2024 Company: 3Q2 2024 Company: 3Q2·24Q3 2024 Company: 3Q4 2024 Company: 3Q4·24Q1 2025 Company: —Q2 2025 Company: —Q2·25Q3 2025 Company: —Q4 2025 Company: —Q4·25Q1 2026 Company: —Q2 2026 Company: —Q2·26Q3 2026 Company: —Q3·260123Q4 2024 Company: 3Q1 2025 Company: —Q1·25Q2 2025 Company: —Q3 2025 Company: —Q3·25Q4 2025 Company: —Q1 2026 Company: —Q1·26Q2 2026 Company: —Q3 2026 Company: —Q3·26
State taxes, € Q3 2026: 74 € · −97.2% vs Q2 2026
02 0004 0006 0008 00010 000Q4 2023 Company: 6 987 €Q4·23Q1 2024 Company: 6 948 €Q2 2024 Company: 7 058 €Q2·24Q3 2024 Company: 6 919 €Q4 2024 Company: 8 394 €Q4·24Q1 2025 Company: 3 021 €Q2 2025 Company: —Q2·25Q3 2025 Company: —Q4 2025 Company: 0 €Q4·25Q1 2026 Company: —Q2 2026 Company: 2 673 €Q2·26Q3 2026 Company: 74 €Q3·2602 0004 0006 0008 00010 000Q4 2024 Company: 8 394 €Q1 2025 Company: 3 021 €Q1·25Q2 2025 Company: —Q3 2025 Company: —Q3·25Q4 2025 Company: 0 €Q1 2026 Company: —Q1·26Q2 2026 Company: 2 673 €Q3 2026 Company: 74 €Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — 74 — —
Q2 2026 — 2 673 — —
Q1 2026 — — — —
Q4 2025 — — — —
Q3 2025 — — — —
Q2 2025 — — — —
Q1 2025 — 3 021 3 186 —
Q4 2024 — 8 394 8 832 3
Q3 2024 — 6 919 7 234 3
Q2 2024 — 7 058 7 384 3
Q1 2024 — 6 948 7 265 3
Q4 2023 — 6 987 7 307 3
Q3 2023 — 5 996 6 233 3
Q2 2023 — 7 871 8 253 2
Q1 2023 — 9 186 9 074 3
Q4 2022 — 9 136 9 596 4
Q3 2022 — 8 499 8 908 4
Q2 2022 — 7 673 8 015 4
Q1 2022 — 7 647 7 986 4

Financials by year

2019 – 2025
Net profit, € thousand 2025: -89 € · +99.9% vs 2024 · industry median 0 € · above 32% of the industry
-125-100-75-50-250252019 Company: -10 179 € Industry median: 3 €20192020 Company: -33 467 € Industry median: 28 €20202021 Company: -113 491 € Industry median: 1 €20212022 Company: -117 378 € Industry median: 0 €20222023 Company: -87 414 € Industry median: 0 €20232024 Company: -84 418 € Industry median: 0 €20242025 Company: -89 € Industry median: 0 €2025-125-100-75-50-250252019 Company: -10 179 € Industry median: 3 €20192020 Company: -33 467 € Industry median: 28 €2021 Company: -113 491 € Industry median: 1 €20212022 Company: -117 378 € Industry median: 0 €2023 Company: -87 414 € Industry median: 0 €20232024 Company: -84 418 € Industry median: 0 €2025 Company: -89 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 77 694 € · +23.6% vs 2024
020 00040 00060 00080 0002019 Company: 31 468 €20192020 Company: 29 497 €20202021 Company: 39 517 €20212022 Company: 39 021 €20222023 Company: 62 891 €20232024 Company: 62 863 €20242025 Company: 77 694 €2025020 00040 00060 00080 0002019 Company: 31 468 €20192020 Company: 29 497 €2021 Company: 39 517 €20212022 Company: 39 021 €2023 Company: 62 891 €20232024 Company: 62 863 €2025 Company: 77 694 €2025
Equity, € 2025: 77 664 € · +30.0% vs 2024
020 00040 00060 00080 0002019 Company: 30 871 €20192020 Company: 6 454 €20202021 Company: 35 163 €20212022 Company: 33 785 €20222023 Company: 60 571 €20232024 Company: 59 753 €20242025 Company: 77 664 €2025020 00040 00060 00080 0002019 Company: 30 871 €20192020 Company: 6 454 €2021 Company: 35 163 €20212022 Company: 33 785 €2023 Company: 60 571 €20232024 Company: 59 753 €2025 Company: 77 664 €2025
Employees 2025: 0 · −100.0% vs 2024 · industry median 1 · above 2% of the industry
0.00.51.01.52.02019 Company: 1 Industry median: 120192020 Company: 2 Industry median: 120202021 Company: 2 Industry median: 120212022 Company: 2 Industry median: 220222023 Company: 2 Industry median: 120232024 Company: 2 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02019 Company: 1 Industry median: 120192020 Company: 2 Industry median: 12021 Company: 2 Industry median: 120212022 Company: 2 Industry median: 22023 Company: 2 Industry median: 120232024 Company: 2 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 — -89 0 77 694 77 664 0
2024 — -84 418 76 392 62 863 59 753 2
2023 — -87 414 72 607 62 891 60 571 2
2022 — -117 378 87 416 39 021 33 785 2
2021 — -113 491 93 140 39 517 35 163 2
2020 — -33 467 29 481 29 497 6 454 2
2019 — -10 179 7 379 31 468 30 871 1

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-0.1 %
Net profit / equity
Return on assets (ROA)
-0.1 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets
Current ratio
105.60
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 30 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 30 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 28 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 28 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 30 Jun 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 14 Jun 2021 Company’s own e-Äriregister
2019 5 Sep 2018 – 31 Dec 2019 20 Nov 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main
Rulings
Number, date Title Deadline State Document
Ä 50101815 / 5
20 Dec 2023
Amendment entry In force
20 Dec 2023
PDF
Ä 50101815 / 4
13 May 2021
Amendment entry In force
13 May 2021
PDF
Ä 50101815 / 3
10 May 2021
Amendment entry In force
10 May 2021
PDF
Ä 50101815 / 2
25 Jun 2019
Amendment entry In force
25 Jun 2019
PDF
Ä 50101815
5 Sep 2018
First entry In force
5 Sep 2018
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data